Atlas Trials

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

Clinical trial NCT01460420 · COMPLETED

Trial details

NCT number
NCT01460420
Sponsor
European Myeloma Network B.V.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic MalignanciesMultiple Myeloma
Start date
2011-11-01
Primary completion
2017-06-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.